I agree with the goal of a “people’s vaccine” – we need vaccines for the entire world.
But I don’t see how these proposals would get us there.
It seems to me that our global situation is very much worse than these proposals assume.
1/
The various "people’s vaccine" proposals want to get rid of intellectual property restrictions for the COVID vaccines so that more vaccines can be produced.
2/
In the past there were such horrible situations in which patent restrictions prevented the world from making progress against diseases.
(For example the patent restrictions on ART that meant that HIV-positive people in poor countries could not get the treatment they needed).
3/
But from what I understand – and I might be wrong – the limit for producing more COVID vaccines now is different.
The limit seems to be the small manufacturing capacity for these vaccines, not any restrictions that would prohibit the use of existing capacity.
4/
For the people’s-vaccine-proposal to possibly work we need to be in a situation in which we have factories that could – and would – produce the vaccines if there were no restrictions on IPs.
It'd be great if we were in that situation. But unfortunately I don’t think we are.
5/
(If we were indeed in the situation that we do have the capacity to produce many more COVID vaccine doses, why would we not be able to increase production with more money?
I think the answer is, that large unused capacities don’t exist.)
6/
Here are 3 proposals – what I’m missing is evidence of the central assumption: that the world has big unusued capacity for producing more COVID vaccines that can't be used at the moment.
If we had unused manufacturing capacity it’d be fantastic.
Getting rid of IP restrictions would then be one option to make progress.
And there would obviously be many more options to produce more vaccines very quickly in that case.
8/
I'm not a big fan of 'intellectual property' obviously
[I spend every day building OurWorldInData.org to make intellectual work freely accessible to as many people as I can].
9/
But in this case I think the discussion of IP restrictions is weakening the public discourse on the central question of 2021.
Getting rid of IP seems to be a proposal that cannot solve the very serious problem the world is facing, which is the limited manufacturing capacity.
10/
I think the discussion needs to be about the more fundamental problem: How can we increase manufacturing capacity as quickly as possible?
And what can we do to be ready for large scale manufacturing as soon as additional vaccines get approved in the coming months?
11/
And more from some time ago, about the great work by CEPI and COVAX that is actually getting to the heart of the problem we are facing – the capacity to develop and manufacture vaccines rapidly:
The good news: “even at this late stage, investment to expand manufacturing capacity would have large benefits.”
The frustrating finding “investing in the amount of capacity recommended by our model (as of August 2020) would have allowed ... the world to complete vaccination by October 2021 rather than June 2022.”
(The benefits would have been $1.14 trillion. Obvs much higher than costs.)
One of the key points to understand in the question of to get the world vaccinated is that the the social value of more vaccines far exceeds the commercial returns to vaccine the manufacturers from installing capacity.
Let’s assume that the cost estimates of that study are much too optimistic and the true cost of producing the vaccine will be $200 billion in the end – it would still be less than the economic losses in just *month* last year.
That’s just the loss in production (4.5% decline of global GDP according to the IMF: imf.org/external/datam…).
The full ‘cost’ of the pandemic is of course much larger than that – the pandemic’s impact on our daily lives, people being sick, people dying.
The point is:
estimate of the pandemic’s cost that is much too low >> estimate of the cost to produce vaccines that is much higher than what this study estimates
This study estimates the cost to produce the missing vaccines to protect *the entire world* from COVID. mdpi.com/2076-393X/9/1/…
Facilities to produce 16 billion doses of a Moderna type vaccines would only cost around $4 billion, ~$2 a jab.
Easily the best deal of the decade.
If this is even remotely true it is unbelievably exciting news. 10- or 100-times that price would be cheap.
This important article outlines a plan for how to pull it off (it's based on the paper above). nytimes.com/2021/01/12/opi…
Here is a perspective on the $4 billion price tag.
For the total cost of the entire production operation of this vaccine this is the relevant table – and the Moderna type vaccine is the one on the left.
CapEx = total capital investment cost
OpEx = annual operating cost
It was wrong to believe that 'saving the economy' was an alternative to 'saving people's lives’.
If anything it is the other way around and the two goals go together so that countries that kept the health impact of the pandemic lower suffered smaller economic consequences.
This isn’t a new insight, it’s just more up to date data.
It was obvious early on in the pandemic and has been said by many economists for months.
@jensspahn Für diejenigen die sagen, dass ein kleines Land wie Israel (8,9 Millionen) nicht mit Deutschland vergleichbar ist:
Baden–Württemberg hat eine Bevölkerung von 11 Millionen.
Während Baden–Württemberg 17,000 Menschen geimpft hat, hat Israel 1,000,000 geimpft.